Natural history of superficial bladder tumors: 10- To 20-year follow-up of treated patients

World Journal of Urology

Volumn 15, Issue 2, 1997, Pages 84-88

  Herr, Harry W ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLADDER TUMOR; DISEASE COURSE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; TUMOR RECURRENCE;

DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; NEOPLASM RECURRENCE, LOCAL; RISK FACTORS; URINARY BLADDER NEOPLASMS;

EID: 0030626585     PISSN: 07244983     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02201977     Document Type: Article

References (13)

1. Badalament RA, Herr HW, Wong Y, et al (1987) A prospective randomized trial of" maintenance versus nonmaintenance intravesical BCG therapy of superficial bladder cancer. .1 Clin Oncol 5: 441-449
2. Herr HW (1992) Intravesical BCG: current results, natural history, and implications for chemoprevention. .1 Cell Biochem 161: 112-119
3. Herr HW. Laudone VP, Whitmore WF (1987) An overview of intravesical therapy for superficial bladder tumors, J Urol 138: 1363-1368
4. Herr HW. Badalament RA. Amato DA. et al (1989) Superficial bladder cancer treated with BCG: a multivariate analysis of factors affecting tumor progression. J Urol 141: 22 29
5. Herr HW. Schwalb DM. Zhang Z-F. et al (1995) Intravesical BCG therapy prevents tumor progression and death from superficial bladder cancer. 10-year followup of a prospective randomized trial. J Clin Oncol 13: 1404-1408
6. Herr HW. Wartinger DD. Oettgen HF (1992) BC'ü tlierapy for superficial bladder cancer: a 1 (1-year followup. J Urol 147: 1020 102?
7. Herr H W, Cookson MS. Soloway S. et al (1996) The treated natural history of high risk superficial bladder cancer: 15 year outcome. J urol (in press)
8. Herr HW. Cookson MS. Soloway S (1996) Upper tract tumors in primary bladder tumor patients followed for 15 years. J Urol (in press)
9. Holmang S. Hedelin H. Anderstrom C. et al (1995) The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and Tl transitional cell cancer of the baldder followed for at least 20 years. J Urol 153: 1823 1X27
10. Kurth K. Tunn U, Ay R. et al (1996) Adjuvant chemotherapy of superficial transitional cell bladder carcinoma: long term results of an EORTC randomized trial comparing doxorubiein. ethoglucid and transurethral resection alone. J Urol (in press)
11. Nadler RB, Catalona WJ. Hudson MA. et al (1994) Durability of the tumor-free response for intravesieal BCG therapy. J Urol 152: 367-373
12. Sarkis AS. Dalbagni G, Cordon-Cardo C. et al (1993) Nuclear overexpresssion of p53 protein in transitional cell bladder carcinoma: a marker of disease progression. J Natl Cancer Inst 85: 53- 59
13. Thompson RA, Campbell EW, Kramer HC. et al (1993) Late invasive recurrence despite long-term surveillance for superficial bladder cancer. J Urol 149: 1010-1014